HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

China · Delayed Price · Currency is CNY

9.05

-0.20 (-2.16%)

Jul 29, 2026, 3:00 PM CST

SHA:600829 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	10,536	10,379	10,048	10,390	9,641	9,315
Revenue Growth	4.14%	3.29%	-3.29%	7.77%	3.50%	16.36%
Gross Profit	867.19	847.01	858.46	986.12	907.13	984.54
Operating Income	231.09	225.78	299.86	411.68	383.01	413.11
Net Income	136.46	133.84	213.27	292.16	264.48	277.3
Earnings Per Share	0.24	0.23	0.37	0.50	0.46	0.48
EPS Growth	-24.53%	-37.25%	-27.00%	10.46%	-4.62%	91.28%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Pharmaceutical Commercial	10,267
Others	71.98
Total	10,339

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	883.88	1,235	1,100	1,314	1,181	800.49
Total Debt	755.18	732.37	900.15	1,019	1,268	1,328
Net Cash (Debt)	128.69	503.04	199.69	295.17	-86.9	-527.08
Net Cash Growth	-	151.91%	-32.35%	-	-	-
Net Cash Per Share	0.22	0.87	0.34	0.51	-0.15	-0.91

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	263.61	299.98	115.44	332.99	307.33	-233
Capital Expenditures	-17.74	-17.16	-8.04	-23.48	-6.42	-12.24
Free Cash Flow	245.87	282.82	107.39	309.5	300.91	-245.24
Free Cash Flow Growth	73.83%	163.34%	-65.30%	2.85%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	8.23%	8.16%	8.54%	9.49%	9.41%	10.57%
Operating Margin	2.19%	2.17%	2.98%	3.96%	3.97%	4.44%
Pretax Margin	1.83%	1.83%	2.88%	3.79%	3.58%	3.85%
Profit Margin	1.29%	1.29%	2.12%	2.81%	2.74%	2.98%
FCF Margin	2.33%	2.73%	1.07%	2.98%	3.12%	-2.63%

Dividends

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Dividend Per Share	0.144
Dividend Per Share Growth	-
Dividend Yield	1.89%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	38.46	46.84	20.39	15.52	13.99	14.05
Forward PE	-	23.62	23.62	23.62	23.62	23.62
P/FCF Ratio	21.34	22.17	40.50	14.65	12.30	-
PS Ratio	0.50	0.60	0.43	0.44	0.38	0.42